Leukaemia Care Logo
donate

Menu

08088 010 444

Our campaigns

We run campaigns throughout the year, and need you to get involved and help raise awareness.

Watch Wait Worry

Join our Watch Wait Worry campaign and help us to improve the support offered to patients on Watch and Wait.

Spot Leukaemia

September is Blood Cancer Awareness Month and we want to raise awareness of leukaemia with our Spot Leukaemia Campaign.

#myCNSmatters

We're saying thank you for the invaluable role that Clinical Nurse Specialists (CNS) have in a leukaemia patient's journey. We want CNSs to know that they matter to patients, to charities and to other healthcare professionals.

Living with Leukaemia

Living with Leukaemia is our annual patient survey that aims to reveal the experience of leukaemia patients from diagnosis through to treatment and living with or beyond blood cancer.

Leukaemia: I wasn’t born yesterday

As part of our report, we undertook a survey of over 1,300 leukaemia patients, to uncover the inequalities that are impacting on cancer survival and patient experience.

What is neutropenia and a healthy diet?

Treatment for all types of cancer acts to ‘kill off’ the harmful tumour cells in the body, and in doing so the treatment can also destroy healthy cells.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

November 15th

Top winter tips for blood cancer patients

Nick York, Campaigns and Advocacy Officer and CLL patient, is here to share his tips for the colder months....

November 12th

How To: Get in touch with your local supermarket

You might think your nearest supermarket is just the place where you do your weekly shop, but it’s also an excellent place to fundraise. Check out our blog and find out how to contact your local supermarket. ...

November 8th

Liposomal cytarabine and daunorubicin approved by NICE

The National Institute of Health and Care Excellence (NICE) have today recommended the use of liposomal cytarabine with daunorubicin to treat previously untreated therapy-related AML and AML with myelodysplastic changes. ...